From 2b194c92bddc27e69d1f27f5a0a3270955f09a2c Mon Sep 17 00:00:00 2001 From: coreyfeez3287 Date: Fri, 3 Apr 2026 10:09:00 +0700 Subject: [PATCH] Add 'Idiopathic hyperprolactinemia-associated hypogonadism in men presenting with normal testosterone levels PLOS One' --- ...-presenting-with-normal-testosterone-levels-PLOS-One.md | 7 +++++++ 1 file changed, 7 insertions(+) create mode 100644 Idiopathic-hyperprolactinemia-associated-hypogonadism-in-men-presenting-with-normal-testosterone-levels-PLOS-One.md diff --git a/Idiopathic-hyperprolactinemia-associated-hypogonadism-in-men-presenting-with-normal-testosterone-levels-PLOS-One.md b/Idiopathic-hyperprolactinemia-associated-hypogonadism-in-men-presenting-with-normal-testosterone-levels-PLOS-One.md new file mode 100644 index 0000000..388daa4 --- /dev/null +++ b/Idiopathic-hyperprolactinemia-associated-hypogonadism-in-men-presenting-with-normal-testosterone-levels-PLOS-One.md @@ -0,0 +1,7 @@ +
+
A study by Pastuszak et al. (2015)355 found a significant increase in biochemical recurrence in high-risk patients who received [testosterone order](http://115.190.101.235:18080/mylessquires91/2578git.archieri.fr/wiki/Serum-Total-Testosterone-Concentrations-in-the-US-Household-Population-from-the-NHANES-2011-2012-Study-Population) therapy after RT or RT/ADT. Currently published studies have not demonstrated an increased risk of biochemical cancer recurrence in post-RP patients who are on [buy testosterone gel online](https://hunthub.com.au/@rashadvenn518?page=about) therapy, [slonec.com](https://slonec.com/employer/oral-testosterone-with-and-without-concomitant-inhibition-of-5%ce%b1-reductase-by-dutasteride-in-hypogonadal-men-for-28-days/) nor does it define the optimal timing for commencement of [buy testosterone supplements](https://bartists.info/@gabriellaevk72?page=about) therapy. It is the opinion of this Panel that until there is definitive evidence demonstrating that testosterone therapy is not safe for use in prostate cancer patients, the decision to commence [testosterone store](http://shqkxh.org:3000/arnetteharms5) therapy in men with a history of prostate cancer is a negotiated decision based on the perceived potential benefit of treatment. While the FDA retains a warning regarding the potential risk of prostate cancer in patients who are prescribed testosterone products ("patients treated with androgens may be at increased risk for prostate cancer"), there is accumulating evidence against a link between [testosterone shop](https://whiskey.tangomedia.fr/@pqiterrie44340?page=about) therapy and prostate cancer development. Included studies had significant heterogeneity with the populations themselves, methods of assessment, study durations, baseline population characteristics, and number of participants, leading the Panel to conclude that there is currently insufficient evidence to determine if testosterone therapy impacts QoL in a meaningful way. Despite the absence of definitive evidence, the Panel recommends that patients with these symptoms be counseled regarding the possibility of improvement on [buy testosterone online without prescription](http://8.130.135.159:3000/aracelisfranci) therapy. Testosterone deficient patients should be informed that low testosterone levels place them at risk for these major cardiovascular events and clinicians should assess all testosterone deficient patients for ASCVD risk factors, both fixed (e.g., older age, male gender) and modifiable (e.g., dyslipidemia, hypertension, diabetes, current cigarette smoking). +Conversely, a recent study exposing patient testes to radiation (3 patients 17Gy and 4 patients 24Gy) demonstrated normal [buy testosterone enanthate online](https://git.kooera.com/valenciasolomo) levels up to 3 years after radiation exposure.147 Specifically, the odds ratio for developing ED in men with total testosterone 6 used a single question to define ED and also showed an increase in ED risk as total [buy testosterone injections](https://gitlab.rails365.net/valeriedyke247) levels decreased. In a small study of young men with acute respiratory infections, mean total [buy testosterone pills](https://git.privezishop.ru/ronniewindham6) levels declined by 10%, with some cohorts experiencing reductions of up to 30%.25 It was decided that a cut-off value was critical to define testosterone deficiency and that this cut-off be based on at least two total testosterone levels drawn in an early morning fashion at the same laboratory using the same assay. +Importantly, we also found that pituitary height returned to the normal range of 4.39 ± 1.37 mm following pharmacological treatment. Nonetheless, several studies have demonstrated the utility of pituitary MRI in the assessment of male patients with hypogonadism. This indicates that the pituitary-gonadal axis may remain intact in these patients, allowing them to respond well to dopamine agonist treatment. Additionally, hyperprolactinemia can affect the vascular and endothelial functions necessary for achieving and maintaining an erection. 12,13 In terms of reproductive health and disease in men, prolactin has been implicated in erectile function and sexual behavior. (3) Cabergoline achieved prolactin normalization more rapidly than bromocriptine in managing idiopathic hyperprolactinemia. (D) Five key domains scores of male sexual function before and after treatment. +A prolactinoma is the most common cause of hyperprolactinemia. They call this idiopathic hyperprolactinemia. Certain health conditions and medications can also cause hyperprolactinemia. +Thresholds for low testosterone were not universal. One RCT by Maggi et al. followed 715 testosterone deficient men for 12 weeks to evaluate the effects of a 2% transdermal [testosterone buy online](https://git.lenfortech.com/xfzlamar753636) agent on sex drive and energy. Of these, 14 biopsies (54%) revealed no cancer, and no patients required additional biopsy for clinical concerns.357 Of these, 14 biopsies (54%) revealed no cancer, and no patients required additional biopsy for clinical concerns.357PSA Monitoring. +
\ No newline at end of file